research communications\(\def\hfill{\hskip 5em}\def\hfil{\hskip 3em}\def\eqno#1{\hfil {#1}}\)

Journal logoCRYSTALLOGRAPHIC
COMMUNICATIONS
ISSN: 2056-9890

Synthesis, crystal structure and Hirshfeld surface analysis of phenyl­methanaminium 2-oxo-2H-chromene-3-carboxyl­ate

crossmark logo

aDepartment of Physics, Yuvaraja's College, University of Mysore, Mysore 570005, Karnataka, India, bDepartment of Biotechnology, U.C.S, Tumkur University, Tumkur, Karnataka-572103, India, cRaman Research Institute, C. V. Raman, Avenue, Sadashivanagar, Bangalore-560080, Karnataka, India, and dDepartment of PG Studies and Research in Physics, Albert Einstein Block, UCS, Tumkur University, Tumkur, Karnataka-572103, India
*Correspondence e-mail: [email protected]

Edited by L. Van Meervelt, Katholieke Universiteit Leuven, Belgium (Received 16 March 2026; accepted 31 March 2026; online 10 April 2026)

The title salt, C7H10N+·C10H4O, formed between 2-oxo-2H-chromene-3-carb­oxy­lic acid and benzyl­amine crystallizes in the triclinic space group P1. Proton transfer from 2-oxo-2H-chromene-3-carb­oxy­lic acid to the NH2 group of benzyl­amine results in a N—H⋯(O,O) hydrogen bond between cation and the carboxylate group of the anion. The 2-oxo-2H-chromene moiety is almost planar with a dihedral angle between the two fused rings of 1.48 (11)°. The dihedral angle between the rings of the anion and cation is 29.49 (10)°. In the crystal, N—H⋯O hydrogen-bonding inter­actions generate an R44(12) synthon parallel to the ac plane. The mol­ecules are linked by further C—H⋯π inter­actions, which consolidate the packing. In addition, ππ stacking inter­actions are observed with centroid-to-centroid distances of 3.5832 (14) and 3.8167 (15) Å. The two-dimensional fingerprint plots indicates that the most important contributions to the crystal packing are from H⋯H (39.7%), H⋯O/O⋯H (30.6%) and H⋯C/C⋯H (20.9%) contacts. The anti­bacterial activity, with MIC values of 30 µg ml−1 against S. aureus and 25 µg ml−1 against E. coli. The lower MIC against E. coli suggests that the compound is more effective against Gram-negative bacteria than Gram-positive bacteria.

1. Chemical context

Chromene and coumarin derivatives possess considerable pharmacological relevance. 2H-Chromene oxime derivatives exhibit anti­proliferative activity against A549, MCF-7 and MDA-MB-231 cell lines (Bandaru et al., 2025View full citation), while coumarin-3-carboxamides demonstrate both anti­bacterial and anti­cancer properties (Phutdhawong et al., 2021View full citation). Similarly, 2-oxo-2H-chromene-3-carboxyl­ates show cytotoxicity toward HepG2, HeLa and HCT116 tumour cell lines (Ji et al., 2021View full citation), and related chromene-3-carboxyl­ates display activity against both Gram-positive and Gram-negative bacteria (Venugopala et al., 2013View full citation). Coumarins are also known inhibitors of cyclo­oxygenase and lipoxygenase pathways (Stefanachi et al., 2018View full citation). Furthermore, chromene derivatives constitute validated pharmacophores in anti­coagulant therapy; clinically used agents inhibit vitamin K epoxide reductase, thereby suppressing vitamin K-dependent clotting factors (Ansell, 2008View full citation).

Beyond pharmaceutical applications, functionalized phenyl­methanaminium iodide salts have been investigated as surface-passivation agents in perovskite solar cells, improving device efficiency and operational stability (Yasa et al., 2025View full citation). Phenyl­methanaminium (benzyl­ammonium) derivatives additionally exhibit diverse biological activities, including anti­tumor (Kemnitzer et al., 2004View full citation), anti­bacterial (Ganapathi et al., 2025View full citation) and anti-inflammatory effects (Cacabelos et al., 2024View full citation). Collectively, these findings highlight the structural versatility and biological significance of chromene and phenyl­methanaminium frameworks and support their continued investigation in crystal engineering and pharmaceutical materials research. s part of our studies in this area, we now report the synthesis and structure of the title salt C7H10N+·C10H4O, (I).

[Scheme 1]

2. Structural commentary

The mol­ecular structure of (I)[link] is shown in Fig. 1[link]. The dihedral angle between the rings of the almost planar (r.m.s. deviation = 0.015 Å) fused ten-membered 2-oxo-2H-chromene moiety is 1.48 (11)° whereas the dihedral angle between 2-oxo-2H-chromene and the aromatic ring of benzyl­amine is 29.49 (10)° for the species in the asymmetric unit. Proton transfer from the 2-oxo-2H-chromene-3-carb­oxy­lic acid to the NH2 substituent of ethyl­benzene lead to the formation of the title salt with a strong N1—H1A⋯O3 hydrogen bond (Table 1[link]). The torsion angles C2—C1—C10—O3 and N1—C17—C11—C16 are 44.9 (3) and 78.0 (3)°, respectively. The angle made by the atoms C11—C17—N1 is 113.3 (2)°.

Table 1
Hydrogen-bond geometry (Å, °)

Cg4 is the centroid of the C11–C16 ring.

D—H⋯A D—H H⋯A DA D—H⋯A
N1—H1A⋯O2 0.89 2.40 3.068 (3) 132
N1—H1A⋯O3 0.89 1.99 2.752 (3) 142
N1—H1B⋯O3i 0.89 1.94 2.791 (3) 158
N1—H1C⋯O4ii 0.89 1.83 2.716 (3) 174
C17—H17BCg4iii 0.97 2.76 3.613 (3) 147
Symmetry codes: (i) Mathematical equation; (ii) Mathematical equation; (iii) Mathematical equation.
[Figure 1]
Figure 1
The title salt with atom-numbering scheme and 50% probability ellipsoids. Dashed lines represent hydrogen bonds.

3. Supra­molecular features

In the crystal, the ions are linked by weak N1—H1A⋯O2 and stronger N1—H1A⋯O3 hydrogen bonds (Table 1[link]). A set of 2-oxo-2H-chromene-3-carboxyl­ate phenyl­methanaminium mol­ecules generate a layered two-dimensional supra­molecular architecture propagating in the ac plane as shown in Fig. 2[link]. The tetramer (two cations and two anions) of mol­ecules generate an R44(12) synthon. Two nitro­gen donor atoms, one from each phenyl­methanaminium cation and four oxygen acceptor atoms, two from each 2-oxo-2H-chromene-3-carboxyl­ate cation, are involved in the synthon. The mol­ecules are linked by C17—H17BCg4 inter­actions (Cg4 is the centroid of the C11–C16 ring; Fig. 3[link]). The crystal packing is further consolidated by ππ stacking inter­actions with centroid-to-centroid distances Cg1⋯Cg2i = 3.5832 (14) Å and Cg2⋯Cg2i = 3.8167 (15) Å [slippage = 1.675 Å; symmetry code: (i) 1 − x, 1 − y, −z′; Cg1 and Cg2 are the centroids of the O1/C2/C1/C9/C8/C3 and C3–C8 rings, respectively; Fig. 4[link]].

[Figure 2]
Figure 2
Packing diagram with N—H⋯O hydrogen bonds shown as blue dashed lines.
[Figure 3]
Figure 3
Partial packing diagram with C—H⋯π inter­actions shown as blue dashed lines.
[Figure 4]
Figure 4
The mol­ecular packing of (I) with ππ stacking inter­actions shown as blue dashed lines.

4. Database survey

A search of the Cambridge Structural Database (CSD, version 5.42, November 2020 update; Groom et al., 2016View full citation) for compounds containing a 2-oxo-2H-chromene-3-carboxyl­ate moiety yielded over thirty entries. Among these, butane-1,4-di­ammonium bis­(2-oxo-2H-chromene-3-carboxyl­ate) CSD (refcode GEPLUK; Das et al., 2012View full citation), 4-(3,4-di­chloro­phen­yl)-N-methyl-1,2,3,4-tetra­hydro­naphthalen-1-aminium 2-oxo-2H-chromene-3-carboxyl­ate (VAHHEU; Escudero et al., 2016View full citation), and 2,6-di­amino­pyridinium 2-oxo-2H-chromene-3-carboxyl­ate (VAXRIX; Yan et al., 2012View full citation) bear similar 2-oxo-2H-chromene substituents and exhibit a dihedral angle between both rings of the ten-membered 2-oxo-2H-chromene moiety of 1.86, 1.96, and 0.44°, respectively, comparable to the title compound [1.48 (11)°].

Furthermore, a search for phenyl­methanaminium fragments also yielded over thirty entries. Among these, three structures are comparable to the title salt: phenyl­meth­an­aminium naphthalene-2-sulfonate (DOXLEK01; Chak­raborty et al., 2020View full citation), dodeca­kis­(phenyl­methanaminium) tris­(benzene-1,2,4,5-tetra­carboxyl­ate) octa­hydrate (EZO­CUU; Ye et al., 2021View full citation), and phenyl­methanaminium 4-(2,4,6-triiso­propyl­benzo­yl) benzoate (CARGIM01; Bąkowicz et al., 2014View full citation). In these structures, the C(ring)—C—N angle is 112.0, 114.8, and 113.5°, comparable to 113.3 (2)° for the title salt.

5. Hirshfeld surface analysis

A Hirshfeld surface analysis (Hirshfeld, 1977View full citation; Spackman & Jayatilaka, 2009View full citation) was carried out using Crystal Explorer 17.5 (Spackman et al., 2021View full citation) to further quantify the inter­molecular inter­actions listed Table 1[link]. The three-dimensional Hirshfeld surfaces plotted over dnorm separately for the 2-oxo-2H-chromene-3-carboxyl­ate moiety (a) and the phenyl­methanaminium fragment (b) are shown in Fig. 5[link]. For both components of the salt, the inter­molecular inter­actions near the red spots are presented in Fig. 6[link]. The two-dimensional fingerprint plots generated separately for the 2-oxo-2H-chromene-3-carboxyl­ate moiety (Fig. 7[link]) and phenyl­methanaminium fragment (Fig. 8[link]), show contributions from O⋯H/H⋯O, H⋯H, H⋯C/C⋯H, C⋯C, and O⋯C/C⋯O contacts of 44.3%, 23.6%, 19.1%, 11.4% and 1.2%, respectively, for the 2-oxo-2H-chromene-3-carboxyl­ate moiety, whereas 26.1%, 47.9%, 23.4%, 1.9% and 0.7%, respectively, for the phenyl­methanaminium fragment. Fig. 9[link]a illustrates the Hirshfeld surface plotted over dnorm generated simultaneously for both fragments. The inter­molecular inter­actions present near the red spots are visualized in Fig. 9[link]b. The 2D finger plot for the combined fragments (Fig. 9[link]c) shows two sharp spikes at di + de ≃ 1.7 Å resulting from O⋯H/H⋯O inter­actions with a contribution of 30.6% (Fig. 9[link]d).

[Figure 5]
Figure 5
View of the three-dimensional Hirshfeld surface of the 2-oxo-2H-chromene-3-carboxyl­ate moiety (a) and the phenyl­methanaminium fragment (b) plotted over dnorm.
[Figure 6]
Figure 6
Hirshfeld surface of (I) plotted over dnorm with the N—H⋯O inter­actions near the red spots shown for the 2-oxo-2H-chromene-3-carboxyl­ate moiety (a) and the phenyl­methanaminium fragment (b)
[Figure 7]
Figure 7
The two-dimensional fingerprint plots for the 2-oxo-2H-chromene-3-carboxyl­ate moiety, showing all inter­actions, and delineated into O⋯H/H⋯O (44.3%), H⋯H (23.6%), H⋯C/C⋯H (19.1%), C⋯C (11.4%), and O⋯C/C⋯O (1.2%) contacts.
[Figure 8]
Figure 8
The two-dimensional fingerprint plots for the phenyl­methanaminium moiety, showing all inter­actions, and delineated into O⋯H/H⋯O (26.1%), H⋯H (47.9%), H⋯C/C⋯H (23.4%), C⋯C (1.9%), and O⋯C/C⋯O (0.7%) contacts.
[Figure 9]
Figure 9
View of the Hirshfeld surface of (I) plotted over dnorm (a), the Hirshfeld surface with the N—H⋯O inter­molecular inter­actions (b),, two-dimensional fingerprint plots for the entire salt (c) and two-dimensional fingerprint plots showing sharp O⋯H/H⋯O spikes (30.6%) (d).

6. Anti­bacterial activity studies

The anti­bacterial activity of the title salt was evaluated by the agar disc-diffusion method following standard bioassay procedures (Atta-ur-Rahman et al., 2001View full citation) and anti­microbial susceptibility testing guidelines recommended by the clinical and laboratory standards institute (Pierce et al., 2023View full citation). The test organisms employed were Staphylococcus aureus (Gram-positive) and Escherichia coli (Gram-negative). The standard anti­bacterial drug ciprofloxacin was used as the reference control. The salt was dissolved in dimethyl sulfoxide (DMSO) to prepare a stock solution (1mg mL−1). Serial dilutions were prepared to obtain concentrations of 100, 75, 50, 40, 35, 30, 25, 20, 15, and 12.5 µg mL−1. A solvent control containing only DMSO was tested under identical experimental conditions to ensure that the solvent had no inhibitory effect on bacterial growth; no zone of inhibition was observed. Sterile filter paper discs (6 mm diameter) were impregnated with 10 µL of each test solution and dried under aseptic conditions. The discs were placed on Mueller–Hinton agar plates previously inoculated with standardized bacterial suspensions (∼108 CFU mL−1; CFU = colony forming unit). The plates were incubated at 37 °C for 16–18 h. After incubation, the zones of inhibition were measured in millimetres (mm). The minimum inhibitory concentration (MIC) was determined as the lowest concentration showing visible inhibition of bacterial growth. The percentage inhibition of the title salt was calculated relative to the standard drug ciprofloxacin, whose inhibition zone was considered as 100%. The standard drug ciprofloxacin shows MIC values of 15 µg mL−1 against S. aureus and 15 µg mL−1 against E. coli. The title salt exhibited moderate anti­bacterial activity, with MIC values of 30 µg mL−1 against S. aureus and 25 µg mL−1 against E. coli, The slightly lower MIC against E. coli suggests that the title salt is marginally more effective against Gram-negative bacteria than Gram-positive bacteria.

7. Synthesis and crystallization

The title salt was prepared by dissolving 2-oxo-2H-chromene-3-carb­oxy­lic acid and phenyl­methanamine in a 1:1 molar ratio in a small excess of ethanol. The mixture was refluxed for 2 h to form a pale-yellow coloured solution. The mixture was cooled to room temperature, after which the solution was allowed to evaporate slowly to obtain crystals of the title salt. ATR-IR (νmax/cm−1): 2923 (N—H stretching of –NH3+), 1709 (C=O lactone stretching), 1570 (C=C aromatic ring stretching), 1320 (aromatic C—H stretching). 1H NMR (400 MHz, DMSO-d6, δ ppm): 4.52 (s, 2H, –CH2), 7.51–7.68 (m, 7H, Ar—H), 7.75–7.83 (m, 4H, Ar—H), 7.96–8.05 (m, 1H, Ar—H), 8.84 (s, 1H). 13C NMR (100 MHz, DMSO-d6, δ ppm): 146.6, 143.5, 140.1, 139.4, 138.5, 137.4, 133.9, 131.9, 129.4, 129.2, 128.4, 124.5, 122.5, 120.1, 120.0.

8. Refinement

Crystal data, data collection and structure refinement details are summarized in Table 2[link]. H atoms were positioned with idealized geometry and refined using a riding model with N—H = 0.89 Å and Uiso(H) = 1.2Ueq(N), and C—H = 0.93 Å for CH groups, 0.97 Å for CH2 groups and Uiso(H) = 1.2Ueq(C).

Table 2
Experimental details

Crystal data
Chemical formula C7H10N+·C10H5O4
Mr 297.31
Crystal system, space group Triclinic, PMathematical equation
Temperature (K) 296
a, b, c (Å) 6.7505 (5), 7.7881 (6), 14.0809 (10)
α, β, γ (°) 79.644 (2), 84.583 (2), 74.960 (2)
V3) 702.39 (9)
Z 2
Radiation type Mo Kα
μ (mm−1) 0.10
Crystal size (mm) 0.27 × 0.24 × 0.22
 
Data collection
Diffractometer Bruker SMART APEXII CCD
Absorption correction Multi-scan (SADABS; Krause et al., 2015View full citation)
Tmin, Tmax 0.975, 0.979
No. of measured, independent and observed [I > 2σ(I)] reflections 21216, 3470, 3076
Rint 0.043
(sin θ/λ)max−1) 0.668
 
Refinement
R[F2 > 2σ(F2)], wR(F2), S 0.080, 0.161, 1.22
No. of reflections 3470
No. of parameters 200
H-atom treatment H-atom parameters constrained
Δρmax, Δρmin (e Å−3) 0.41, −0.38
Computer programs: APEX2 and SAINT (Bruker, 2017View full citation), SHELXT2018/3 (Sheldrick, 2015aView full citation), SHELXL2019/2 (Sheldrick, 2015bView full citation), Mercury (Macrae et al., 2020View full citation) and publCIF (Westrip, 2010View full citation).

Supporting information


Computing details top

Phenylmethanaminium 2-oxo-2H-chromene-3-carboxylate top
Crystal data top
C7H10N+·C10H5O4Z = 2
Mr = 297.31F(000) = 312
Triclinic, P1co-crystal
Hall symbol: -P 1Dx = 1.406 Mg m3
a = 6.7505 (5) ÅMo Kα radiation, λ = 0.71073 Å
b = 7.7881 (6) ÅCell parameters from 3077 reflections
c = 14.0809 (10) Åθ = 2–29°
α = 79.644 (2)°µ = 0.10 mm1
β = 84.583 (2)°T = 296 K
γ = 74.960 (2)°Prism, colourless
V = 702.39 (9) Å30.27 × 0.24 × 0.22 mm
Data collection top
Bruker SMART APEXII CCD
diffractometer
3470 independent reflections
Radiation source: fine-focus sealed tube3076 reflections with I > 2σ(I)
Graphite monochromatorRint = 0.043
Detector resolution: 1.97 pixels mm-1θmax = 28.4°, θmin = 3.0°
φ and Ω scansh = 89
Absorption correction: multi-scan
(SADABS; Krause et al., 2015)
k = 1010
Tmin = 0.975, Tmax = 0.979l = 1818
21216 measured reflections
Refinement top
Refinement on F2Primary atom site location: structure-invariant direct methods
Least-squares matrix: fullSecondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.080Hydrogen site location: inferred from neighbouring sites
wR(F2) = 0.161H-atom parameters constrained
S = 1.22 w = 1/[σ2(Fo2) + (0.0372P)2 + 0.9952P]
where P = (Fo2 + 2Fc2)/3
3470 reflections(Δ/σ)max < 0.001
200 parametersΔρmax = 0.41 e Å3
0 restraintsΔρmin = 0.38 e Å3
0 constraints
Special details top

Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes.

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2) top
xyzUiso*/Ueq
O10.1596 (2)0.3659 (2)0.10082 (12)0.0219 (4)
O20.0292 (2)0.4790 (2)0.22176 (13)0.0235 (4)
O40.4445 (2)0.5775 (2)0.33560 (13)0.0225 (4)
O30.2113 (3)0.4216 (2)0.39393 (12)0.0227 (4)
C30.3466 (4)0.3068 (3)0.05274 (17)0.0198 (5)
C80.5288 (4)0.3028 (3)0.09229 (17)0.0194 (5)
C10.3342 (3)0.4218 (3)0.23032 (17)0.0185 (5)
C90.5163 (4)0.3665 (3)0.18286 (17)0.0202 (5)
H90.6362600.3696720.2092570.024*
N10.2030 (3)0.4531 (3)0.43174 (14)0.0181 (4)
H1A0.0930730.4645090.3933470.022*
H1B0.2166820.5205520.4778330.022*
H1C0.3144080.4890190.3971460.022*
C100.3279 (3)0.4804 (3)0.32791 (17)0.0186 (5)
C70.7141 (4)0.2416 (3)0.04013 (18)0.0238 (5)
H70.8384990.2368710.0650440.029*
C40.3414 (4)0.2571 (3)0.03637 (18)0.0251 (5)
H40.2172040.2636510.0620420.030*
C20.1425 (3)0.4249 (3)0.18859 (16)0.0177 (5)
C50.5256 (4)0.1976 (4)0.08612 (18)0.0280 (6)
H50.5257080.1631330.1460240.034*
C120.3402 (4)0.0714 (3)0.39657 (19)0.0278 (6)
H120.4608310.1090110.4331330.033*
C110.1712 (4)0.1384 (3)0.40422 (17)0.0216 (5)
C160.0057 (4)0.0840 (3)0.34773 (18)0.0248 (5)
H160.1187530.1295610.3513360.030*
C140.1528 (5)0.1060 (4)0.2794 (2)0.0342 (7)
H140.1457680.1881000.2379690.041*
C170.1777 (4)0.2615 (3)0.47659 (18)0.0268 (6)
H17A0.2906820.2522590.5235980.032*
H17B0.0515460.2213270.5108380.032*
C130.3301 (5)0.0512 (4)0.3348 (2)0.0337 (6)
H130.4431880.0964140.3307750.040*
C60.7118 (4)0.1886 (4)0.04749 (19)0.0268 (5)
H60.8349020.1465060.0813270.032*
C150.0152 (4)0.0376 (4)0.28602 (19)0.0307 (6)
H150.1348840.0738520.2486260.037*
Atomic displacement parameters (Å2) top
U11U22U33U12U13U23
O10.0168 (8)0.0306 (9)0.0216 (9)0.0079 (7)0.0042 (6)0.0082 (7)
O20.0143 (8)0.0301 (9)0.0261 (9)0.0030 (7)0.0025 (7)0.0075 (7)
O40.0149 (8)0.0278 (9)0.0288 (9)0.0063 (7)0.0049 (7)0.0116 (7)
O30.0173 (8)0.0328 (9)0.0207 (9)0.0074 (7)0.0012 (6)0.0098 (7)
C30.0197 (11)0.0202 (11)0.0208 (11)0.0068 (9)0.0022 (9)0.0033 (9)
C80.0188 (11)0.0207 (11)0.0207 (11)0.0069 (9)0.0033 (9)0.0045 (9)
C10.0167 (11)0.0211 (11)0.0195 (11)0.0063 (9)0.0048 (9)0.0035 (9)
C90.0175 (11)0.0245 (11)0.0212 (12)0.0072 (9)0.0060 (9)0.0051 (9)
N10.0117 (9)0.0227 (10)0.0212 (10)0.0027 (7)0.0044 (7)0.0073 (8)
C100.0125 (10)0.0220 (11)0.0218 (11)0.0002 (8)0.0066 (8)0.0075 (9)
C70.0175 (11)0.0296 (13)0.0257 (13)0.0061 (9)0.0019 (9)0.0073 (10)
C40.0253 (13)0.0322 (13)0.0213 (12)0.0107 (10)0.0061 (10)0.0059 (10)
C20.0164 (11)0.0200 (11)0.0184 (11)0.0063 (9)0.0039 (8)0.0032 (9)
C50.0349 (14)0.0346 (14)0.0182 (12)0.0114 (11)0.0009 (10)0.0100 (10)
C120.0268 (13)0.0245 (12)0.0281 (14)0.0038 (10)0.0011 (10)0.0009 (10)
C110.0297 (13)0.0167 (11)0.0168 (11)0.0023 (9)0.0012 (9)0.0032 (9)
C160.0266 (13)0.0250 (12)0.0223 (12)0.0047 (10)0.0022 (10)0.0042 (10)
C140.0532 (18)0.0216 (12)0.0283 (14)0.0036 (12)0.0131 (13)0.0080 (11)
C170.0380 (15)0.0203 (12)0.0203 (12)0.0020 (10)0.0030 (10)0.0054 (9)
C130.0354 (15)0.0308 (14)0.0386 (16)0.0138 (12)0.0152 (12)0.0003 (12)
C60.0248 (13)0.0305 (13)0.0255 (13)0.0074 (10)0.0052 (10)0.0082 (10)
C150.0340 (15)0.0288 (13)0.0236 (13)0.0043 (11)0.0028 (11)0.0066 (11)
Geometric parameters (Å, º) top
O1—C21.379 (3)C4—C51.380 (4)
O1—C31.383 (3)C4—H40.9300
O2—C21.206 (3)C5—C61.397 (4)
O4—C101.249 (3)C5—H50.9300
O3—C101.261 (3)C12—C131.387 (4)
C3—C41.384 (3)C12—C111.393 (4)
C3—C81.389 (3)C12—H120.9300
C8—C71.405 (3)C11—C161.385 (4)
C8—C91.437 (3)C11—C171.510 (3)
C1—C91.348 (3)C16—C151.382 (4)
C1—C21.463 (3)C16—H160.9300
C1—C101.517 (3)C14—C131.379 (4)
C9—H90.9300C14—C151.389 (4)
N1—C171.484 (3)C14—H140.9300
N1—H1A0.8900C17—H17A0.9700
N1—H1B0.8900C17—H17B0.9700
N1—H1C0.8900C13—H130.9300
C7—C61.372 (4)C6—H60.9300
C7—H70.9300C15—H150.9300
C2—O1—C3122.79 (17)O2—C2—C1126.6 (2)
O1—C3—C4116.9 (2)O1—C2—C1116.8 (2)
O1—C3—C8120.6 (2)C4—C5—C6120.7 (2)
C4—C3—C8122.5 (2)C4—C5—H5119.6
C3—C8—C7118.1 (2)C6—C5—H5119.6
C3—C8—C9118.0 (2)C13—C12—C11120.5 (3)
C7—C8—C9123.9 (2)C13—C12—H12119.8
C9—C1—C2120.5 (2)C11—C12—H12119.8
C9—C1—C10119.8 (2)C16—C11—C12119.0 (2)
C2—C1—C10119.8 (2)C16—C11—C17120.6 (2)
C1—C9—C8121.3 (2)C12—C11—C17120.3 (2)
C1—C9—H9119.3C15—C16—C11120.3 (2)
C8—C9—H9119.3C15—C16—H16119.8
C17—N1—H1A109.5C11—C16—H16119.8
C17—N1—H1B109.5C13—C14—C15119.5 (3)
H1A—N1—H1B109.5C13—C14—H14120.3
C17—N1—H1C109.5C15—C14—H14120.3
H1A—N1—H1C109.5N1—C17—C11113.3 (2)
H1B—N1—H1C109.5N1—C17—H17A108.9
O4—C10—O3126.4 (2)C11—C17—H17A108.9
O4—C10—O3126.4 (2)N1—C17—H17B108.9
O4—C10—C1116.4 (2)C11—C17—H17B108.9
O3—C10—C1117.1 (2)H17A—C17—H17B107.7
O3—C10—C1117.1 (2)C14—C13—C12120.1 (3)
C6—C7—C8120.1 (2)C14—C13—H13119.9
C6—C7—H7119.9C12—C13—H13119.9
C8—C7—H7119.9C7—C6—C5120.3 (2)
C5—C4—C3118.2 (2)C7—C6—H6119.8
C5—C4—H4120.9C5—C6—H6119.8
C3—C4—H4120.9C16—C15—C14120.5 (3)
O2—C2—O1116.62 (19)C16—C15—H15119.7
O2—C2—O1116.62 (19)C14—C15—H15119.7
O2—C2—C1126.6 (2)
C2—O1—C3—C4177.8 (2)C3—O1—C2—C10.3 (3)
O1—C3—C8—C7180.0 (2)C9—C1—C2—O2176.4 (2)
C4—C3—C8—C71.6 (4)C10—C1—C2—O23.9 (4)
O1—C3—C8—C91.7 (3)C9—C1—C2—O2176.4 (2)
C4—C3—C8—C9176.7 (2)C10—C1—C2—O23.9 (4)
C2—C1—C9—C82.4 (4)C9—C1—C2—O11.2 (3)
C10—C1—C9—C8177.3 (2)C10—C1—C2—O1178.5 (2)
C3—C8—C9—C12.6 (3)C3—C4—C5—C60.2 (4)
C7—C8—C9—C1179.2 (2)C13—C12—C11—C161.4 (4)
C9—C1—C10—O442.9 (3)C13—C12—C11—C17175.7 (2)
C2—C1—C10—O4137.4 (2)C12—C11—C16—C151.2 (4)
C9—C1—C10—O3134.8 (2)C17—C11—C16—C15175.9 (2)
C2—C1—C10—O344.9 (3)C16—C11—C17—N178.0 (3)
C9—C1—C10—O3134.8 (2)C12—C11—C17—N1104.9 (3)
C2—C1—C10—O344.9 (3)C15—C14—C13—C120.0 (4)
C3—C8—C7—C60.3 (4)C11—C12—C13—C140.8 (4)
C9—C8—C7—C6177.8 (2)C8—C7—C6—C50.9 (4)
O1—C3—C4—C5180.0 (2)C4—C5—C6—C71.0 (4)
C8—C3—C4—C51.5 (4)C11—C16—C15—C140.4 (4)
C3—O1—C2—O2177.5 (2)C13—C14—C15—C160.2 (4)
C3—O1—C2—O2177.5 (2)
Hydrogen-bond geometry (Å, º) top
Cg4 is the centroid of the C11–C16 ring.
D—H···AD—HH···AD···AD—H···A
N1—H1A···O20.892.403.068 (3)132
N1—H1A···O30.891.992.752 (3)142
N1—H1B···O3i0.891.942.791 (3)158
N1—H1C···O4ii0.891.832.716 (3)174
C17—H17B···Cg4iii0.972.763.613 (3)147
Symmetry codes: (i) x, y+1, z+1; (ii) x1, y, z; (iii) x, y, z+1.
 

Acknowledgements

The authors acknowledge the iSTEM, CISEE and are thankful to BSPM's lab for use of their computing facilities. MSK is grateful to the Department of PG Studies and Research in Physics, Albert Einstein Block, UCS, Tumkur University, Tumkur.

References

Return to citationAnsell, J., Hirsh, J., Hylek, E., Jacobson, A., Crowther, M. & Palareti, G. (2008). Chest 133, 160S-198S.  Web of Science CrossRef PubMed CAS Google Scholar
Return to citationAtta-ur-Rahman, Choudhary, M. I. & Thomsen, W. J. (2001). Bioassay Techniques for Drug Development 1st ed. Newark: CRC press.  Google Scholar
Return to citationBąkowicz, J., Olejarz, J. & Turowska-Tyrk, I. (2014). J. Photochem. Photobiol. Chem. 273, 34–42.  Google Scholar
Return to citationBandaru, V., Latambale, G., Kumar, L., Dhuguru, J., Kumari, K. S., Jadhav, V., Juvale, K. & Vidavalur, S. (2025). Ann. Pharm. Franç. https://doi.org/10.1016/j.pharma.2025.11.004  Google Scholar
Return to citationBruker (2017). APEX2 and SAINT. Bruker AXS Inc., Madison, Wisconsin, USA.  Google Scholar
Return to citationCacabelos, R., Martínez-Iglesias, O., Cacabelos, N., Carrera, I., Corzo, L. & Naidoo, V. (2024). Life 14, 1555.  Web of Science CrossRef PubMed Google Scholar
Return to citationChakraborty, P., Das, B., Pal, P., Datta, S., Bera, S. & Dastidar, P. (2020). Chem. Commun. 56, 5251–5254.  Web of Science CSD CrossRef CAS Google Scholar
Return to citationDas, U. K., Puranik, V. G. & Dastidar, P. (2012). Cryst. Growth Des. 12, 5864–5868.  Web of Science CSD CrossRef CAS Google Scholar
Return to citationEscudero, G. E., Laino, C. H., Echeverría, G. A., Piro, O. E., Martini, N., Rodríguez, A. N., Martínez Medina, J. J., López Tévez, L. L., Ferrer, E. G. & Williams, P. A. (2016). Chem. Biol. Interact. 249, 46–55.  Web of Science CSD CrossRef CAS PubMed Google Scholar
Return to citationGanapathi, P., Ganesan, K., Vijaykanth, N., Muthialu, S., Ahmed, S. S., Alam, M. M. & Hussien, M. (2025). RSC Adv. 15, 35115–35136.  Web of Science CrossRef CAS PubMed Google Scholar
Return to citationGroom, C. R., Bruno, I. J., Lightfoot, M. P. & Ward, S. C. (2016). Acta Cryst. B72, 171–179.  Web of Science CrossRef IUCr Journals Google Scholar
Return to citationHirshfeld, H. L. (1977). Theor. Chim. Acta 44, 129–138.  CrossRef CAS Web of Science Google Scholar
Return to citationJi, H., Tan, Y., Gan, N., Zhang, J., Li, S., Zheng, X., Wang, Z. & Yi, W. (2021). Bioorg. Med. Chem. 35, 115870.  Web of Science CrossRef Google Scholar
Return to citationKemnitzer, W., Drewe, J., Jiang, S., Zhang, H., Wang, Y., Zhao, J., Jia, S., Herich, J., Labreque, D., Storer, R., Meerovitch, K., Bouffard, D., Rej, R., Denis, R., Blais, C., Lamothe, S., Attardo, G., Gourdeau, H., Tseng, B., Kasibhatla, S. & Cai, S. X. (2004). J. Med. Chem. 47, 6299–6310.  Web of Science CrossRef PubMed CAS Google Scholar
Return to citationKrause, L., Herbst-Irmer, R., Sheldrick, G. M. & Stalke, D. (2015). J. Appl. Cryst. 48, 3–10.  Web of Science CSD CrossRef ICSD CAS IUCr Journals Google Scholar
Return to citationMacrae, C. F., Sovago, I., Cottrell, S. J., Galek, P. T. A., McCabe, P., Pidcock, E., Platings, M., Shields, G. P., Stevens, J. S., Towler, M. & Wood, P. A. (2020). J. Appl. Cryst. 53, 226–235.  Web of Science CrossRef CAS IUCr Journals Google Scholar
Return to citationPhutdhawong, W., Chuenchid, A., Taechowisan, T., Sirirak, J. & Phutdhawong, W. S. (2021). Molecules 26, 1653.  Web of Science CrossRef PubMed Google Scholar
Return to citationPierce, V. M., Bhowmick, T. & Simner, P. J. (2023). J. Clin. Microbiol. 61, e00074–22.  Web of Science CrossRef PubMed Google Scholar
Return to citationSheldrick, G. M. (2015a). Acta Cryst. A71, 3–8.  Web of Science CrossRef IUCr Journals Google Scholar
Return to citationSheldrick, G. M. (2015b). Acta Cryst. C71, 3–8.  Web of Science CrossRef IUCr Journals Google Scholar
Return to citationSpackman, M. A. & Jayatilaka, D. (2009). CrystEngComm 11, 19–32.  Web of Science CrossRef CAS Google Scholar
Return to citationSpackman, P. R., Turner, M. J., McKinnon, J. J., Wolff, S. K., Grimwood, D. J., Jayatilaka, D. & Spackman, M. A. (2021). J. Appl. Cryst. 54, 1006–1011.  Web of Science CrossRef CAS IUCr Journals Google Scholar
Return to citationStefanachi, A., Leonetti, F., Pisani, L., Catto, M. & Carotti, A. (2018). Molecules 23, 250.  Web of Science CrossRef PubMed Google Scholar
Return to citationVenugopala, K. N., Rashmi, V. & Odhav, B. (2013). BioMed Res. Int. 963248.  Google Scholar
Return to citationWestrip, S. P. (2010). J. Appl. Cryst. 43, 920–925.  Web of Science CrossRef CAS IUCr Journals Google Scholar
Return to citationYan, D., Delori, A., Lloyd, G. O., Patel, B., Friščić, T., Day, G. M., Bučar, D. K., Jones, W., Lu, J., Wei, M., Evans, D. G. & Duan, X. (2012). CrystEngComm 14, 5121–5123.  Web of Science CSD CrossRef CAS Google Scholar
Return to citationYaşa, M., Celik, E. B., Gao, X. X., Karabağ, Z. G., Gunes, U., Syzgantseva, O. A., Syzgantseva, M. A., Zhong, L., Züttel, A., Dyson, P. J., Nazeeruddin, M. K., Toppare, L., Yerci, S. & Gunbas, G. (2025). ACS Appl. Mater. Interfaces. 17, 18450–18457.  Web of Science PubMed Google Scholar
Return to citationYe, W., Ma, H., Shi, H., Wang, H., Lv, A., Bian, L., Zhang, M., Ma, C., Ling, K., Gu, M., Mao, Y., Yao, X., Gao, C., Shen, K., Jia, W., Zhi, J., Cai, S., Song, Z., Li, J., Zhang, Y., Lu, S., Liu, K., Dong, C., Wang, Q., Zhou, Y., Yao, W., Zhang, Y., Zhang, H., Zhang, Z., Hang, X., An, Z., Liu, X. & Huang, W. (2021). Nat. Mater. 20, 1539–1544.  Web of Science CSD CrossRef CAS PubMed Google Scholar

This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.

Journal logoCRYSTALLOGRAPHIC
COMMUNICATIONS
ISSN: 2056-9890
Follow Acta Cryst. E
Sign up for e-alerts
Follow Acta Cryst. on Twitter
Follow us on facebook
Sign up for RSS feeds